Publikationen in Zusammenarbeit mit Forschern von Masaryk Memorial Cancer Institute (3)

2017

  1. Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial

    Cancer Chemotherapy and Pharmacology, Vol. 80, Núm. 3, pp. 599-608

2016

  1. Subgroup analysis in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression

    Annals of Oncology, Vol. 27, Núm. 11, pp. 2082-2089

2015

  1. Panitumumab use in metastatic colorectal cancer and patterns of KRAS testing: Results from a Europe-wide physician survey and medical records review

    PLoS ONE, Vol. 10, Núm. 10